Exercise may ease hormone therapy side effects in prostate cancer

NCT ID NCT06238596

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests whether a 12-week, drug-free exercise program can help men with metastatic prostate cancer who are starting hormone therapy. The program includes supervised sessions of aerobic, resistance, balance, and flexibility exercises. The main goal is to see if patients can stick with the program, and to check if it reduces side effects like muscle weakness, fatigue, and falls.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER (PCA) IN ADT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SOC Oncologia Medica Provinciale

    Reggio Emilia, Italy, 42123, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.